abstract |
The compounds of the present invention and pharmaceutically acceptable compositions thereof, are useful as modulators of the ATP Linker Cassette ("ABC") transporters or their fragments, including the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR "). The present invention also relates to methods for treating diseases mediated by the ABC transporter, using the compounds of the present invention. |